Fillers
5 min readTemple Filler: Treating Structural Facial Ageing
Educational reading for licensed practitioners — not clinical or injection guidance.
The temples are one of the most overlooked regions in facial rejuvenation, yet they sit at the top of the face's structural framework. When they hollow, the effect ripples downward: the brow drops, the upper cheek loses support and the whole face can read as tired or gaunt long before the patient can say why. Understanding the temple as a foundation, rather than a cosmetic afterthought, changes how the upper face is treated.
Why the Temple Matters
Ageing in the temple is not only skin-deep. Bone remodels, deep and superficial fat pads deflate, and the underlying scaffold shrinks. The visible consequences are characteristic:
- A hollow or concave contour where there was once a gentle convexity.
- Skeletonisation, with the bony orbital rim and temporal fusion line becoming more prominent.
- A subtle descent of the lateral brow and a loss of the smooth transition from forehead to cheek.
Because the temple supports the tail of the brow and the upper lateral face, restoring it can produce a soft lift and a more open upper-eye appearance without touching the brow or eyelid directly. This is why the region is increasingly treated early in a structural plan rather than last.
Anatomy Makes This a High-Skill Area
The temple is anatomically busy. Several vessels — including branches of the superficial temporal and the deep temporal system — and the temporal branch of the facial nerve run through the region, and the tissue planes are thin and closely layered. There are two broadly recognised approaches: a deep, supraperiosteal placement against the bone, and more superficial subcutaneous placement, each with its own considerations. This article is educational and does not set out an injection technique; safe temple treatment depends on region-specific training and a detailed grasp of the anatomy in front of you.
Choosing a Product
The temple rewards a product that provides quiet, even support rather than a sharp edge. Two families are commonly used.
For deep, structural volumising, a robust volumiser holds up well against the bony platform. Juvederm Voluma is a firm, high-lift HA frequently chosen for supraperiosteal placement, and Restylane Lyft is a similarly established volumiser with a long track record in deep tissue. Being hyaluronic-acid products, both remain reversible with hyaluronidase — a reassuring feature in a vascular zone.
Galderma also markets Restylane Contour for mid-to-deep volumising; where it is not stocked, another resilient volumiser from the same tier can fulfil the same role. The Restylane Volyme gel is one such flexible volumiser used for broad support across the upper and mid-face.
For patients whose temple loss is part of a wider, diffuse deflation, a collagen biostimulator such as poly-L-lactic acid can rebuild foundation gradually across the upper face rather than filling a single hollow — a different philosophy that suits global ageing well. The choice between an immediate HA volumiser and a slow-build biostimulator depends on how localised the hollow is and how the patient wants the change to unfold.
Fitting the Temple into a Plan
Treating the temple rarely stands alone. Because it underpins the brow and lateral cheek, it is often addressed alongside — or before — the mid-face, so that cheek support is built on a restored upper framework rather than in isolation. A few practical principles:
- Assess top-down. A flat mid-face may be partly a consequence of an unsupported temple; treating the temple first can change how much the cheek then needs.
- Aim for restoration, not augmentation. The goal is to return a gentle convexity, not to over-project. Over-filling reads as unnatural quickly in this region.
- Volume, not laxity. Where the issue is genuine skin laxity or brow descent from soft-tissue drop, filler supports but does not lift surgically; set expectations accordingly.
Standard injectable exclusions apply throughout: hypersensitivity, pregnancy and lactation, active infection or inflammation at the site, and bleeding disorders.
The Takeaway
The temple is a structural keystone, not a cosmetic detail. Restoring a hollow temple can soften the upper face, support the brow and improve the transition into the cheek, which is why it increasingly features early in a full-face plan. Firm, reversible HA volumisers such as Voluma and Lyft are the workhorses here, with biostimulators an option for diffuse loss — but the anatomy makes training and careful assessment the real prerequisites.
Review the structural options in the dermal fillers range.